Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;19(1):1-2.
doi: 10.1038/s41423-021-00738-0. Epub 2021 Dec 19.

Immune regulation in the tumor microenvironment and its relevance in cancer therapy

Weiping Zou  1   2
Affiliations
Editorial

Immune regulation in the tumor microenvironment and its relevance in cancer therapy

Weiping Zou. Cell Mol Immunol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Dr. Weiping Zou
See this image and copyright information in PMC

Comment on

References

    1. Zou W. Immunosuppressive networks in the tumor microenvironment and their therapeutic relevance. Nat Rev Cancer. 2005;5:263–74. doi: 10.1038/nrc1586. - DOI - PubMed
    1. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med. 2003;9:562–7. doi: 10.1038/nm863. - DOI - PubMed
    1. Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest. 2018;128:580–8. doi: 10.1172/JCI96061. - DOI - PMC - PubMed
    1. Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J Clin Invest. 2018;128:805–15. doi: 10.1172/JCI96113. - DOI - PMC - PubMed
    1. Oh SA, Wu DC, Cheung J, Navarro A, Xiong H, Cubas R, et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat Cancer. 2020;1:681–91. doi: 10.1038/s43018-020-0075-x. - DOI - PubMed